clonidine has been researched along with 6-anilino-5,8-quinolinedione in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Diamond, J; Harris, KH; MacLeod, KM; Ng, DD | 1 |
Garvin, JL; Plato, CF | 1 |
2 other study(ies) available for clonidine and 6-anilino-5,8-quinolinedione
Article | Year |
---|---|
Evidence that cGMP is the mediator of endothelium-dependent inhibition of contractile responses of rat arteries to alpha-adrenoceptor stimulation.
Topics: Acetylcholine; Adrenergic alpha-Agonists; Aminoquinolines; Animals; Aorta; Clonidine; Cyclic GMP; Endothelium; In Vitro Techniques; Male; Mesenteric Arteries; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Norepinephrine; Rats; Rats, Inbred Strains; Vasodilator Agents | 1987 |
Alpha(2)-adrenergic-mediated tubular NO production inhibits thick ascending limb chloride absorption.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Aminoquinolines; Animals; Biological Transport; Chlorides; Clonidine; Enzyme Inhibitors; In Vitro Techniques; Loop of Henle; Male; Nephrons; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Phosphatidylinositol 3-Kinases; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Yohimbine | 2001 |